About us
vivoVerse, Inc., formerly operating as Newormics LLC, develops and manufactures advanced microfluidics, automation, and AI/ML technologies to rapidly and ethically test toxicology/safety profiles of chemicals using C. elegans as a New Approach Methodology (NAM). With a new class of instruments, software, and services, we aim at reducing animal testing while providing rapid and cost-effective services to our industry customers for bringing their new products to the market.
Our Team

Adela Ben-Yakar, PhD
Chief Executive Officer, Co-Founder
READ BIO→

Sudip Mondal, PhD
Director of Science
READ BIO→

Evan Hegarty, MSE
Director of Manufacturing, Co-Founder
READ BIO→

Gina Lento, PhD
Head of Operations
READ BIO→

Adam Laing, PhD
Research Scientist
READ BIO→

Jacob Moore, PhD
Manufacturing and Automation Engineer
READ BIO→

Nicholas Chavez
Software Engineer
READ BIO→
Customers
